Beam Therapeutics Inc. (BEAM) Insider Trading

Over the last 3 months, BEAM insiders made 0 open-market buys and 6 sales, a net sale of -$2.0M (SEC Form 4). Over the last 6 months, 196 institutions increased and 124 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
6
Net (3m)
-$2.0M
Insider trades by month Buys Sells
Jul
Aug
Oct
Jan
Feb
Apr
Context3-month price +28.7%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Apr 6, 2026Bellon Christineofficer: Chief Legal OfficerSell5,956$24.58
Apr 6, 2026Cavanagh Bethany Jofficer: SVP, Finance and TreasurerSell3,242$24.58
Apr 6, 2026Ciaramella Giuseppeofficer: PresidentSell11,810$24.58
Apr 6, 2026Evans John M.director, officer: CEOSell30,078$24.58
Apr 6, 2026Simon Amyofficer: Chief Medical OfficerSell6,700$24.58
Apr 2, 2026Ciaramella Giuseppeofficer: PresidentGrant40,000
Apr 2, 2026Cavanagh Bethany Jofficer: SVP, Finance and TreasurerGrant20,000
Apr 2, 2026Bellon Christineofficer: Chief Legal OfficerGrant20,000
Apr 2, 2026Simon Amyofficer: Chief Medical OfficerGrant31,750
Apr 2, 2026Emany Sravan Kumarofficer: Chief Financial OfficerGrant31,750
Apr 1, 2026Evans John M.director, officer: CEOSell25,000$22.37
Apr 1, 2026Evans John M.director, officer: CEOGrant90,000
Apr 1, 2026Evans John M.director, officer: CEOOption25,000$0.67
Feb 26, 2026Ciaramella Giuseppeofficer: PresidentOption35,000$17.00
Feb 26, 2026Ciaramella Giuseppeofficer: PresidentSell35,000$32.00
Feb 2, 2026Evans John M.director, officer: CEOOption19,336$0.67
Feb 2, 2026Ciaramella Giuseppeofficer: PresidentGrant80,000$27.62
Feb 2, 2026Simon Amyofficer: Chief Medical OfficerGrant88,500$27.62
Feb 2, 2026Evans John M.director, officer: CEOOption5,664$0.67
Feb 2, 2026Evans John M.director, officer: CEOOption25,000$0.67
Feb 2, 2026Evans John M.director, officer: CEOGrant180,000$27.62
Feb 2, 2026Evans John M.director, officer: CEOSell2,906$29.00
Feb 2, 2026Bellon Christineofficer: Chief Legal OfficerGrant40,000$27.62
Feb 2, 2026Evans John M.director, officer: CEOSell8,667$29.74
Feb 2, 2026Evans John M.director, officer: CEOSell22,094$28.27
Feb 2, 2026Emany Sravan Kumarofficer: Chief Financial OfficerGrant63,500$27.62
Feb 2, 2026Cavanagh Bethany Jofficer: SVP, Finance and TreasurerGrant40,000$27.62
Feb 2, 2026Evans John M.director, officer: CEOSell16,333$29.19
Jan 26, 2026Cavanagh Bethany Jofficer: SVP, Finance and TreasurerSell6,198$35.00
Jan 26, 2026Bellon Christineofficer: Chief Legal OfficerSell1,371$34.00

Source: BEAM SEC Form 4 filings, latest Apr 6, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their BEAM positions over the last 6 months (SEC Form 13F).

Increased
196
New positions
100
Reduced
124
Sold out
70
Largest moves
InstitutionActionSharesFiled
ARK INVESTMENT MANAGEMENT LLCIncreased12.5MFeb 11, 2026
FMR LLCIncreased12.5MMay 15, 2026
ARK INVESTMENT MANAGEMENT LLCReduced12.1MMay 12, 2026
FMR LLCIncreased11.9MFeb 17, 2026
FARALLON CAPITAL MANAGEMENT LLCIncreased10.1MMay 15, 2026
FARALLON CAPITAL MANAGEMENT LLCUnchanged10.1MFeb 17, 2026
FARALLON CAPITAL MANAGEMENT LLCIncreased10.1MFeb 17, 2026
VANGUARD GROUP INCReduced9.2MJan 29, 2026
BLACKROCK, INC.Increased8.5MMay 13, 2026
BLACKROCK, INC.Increased8.5MFeb 12, 2026
STATE STREET CORPIncreased5.7MMay 15, 2026
STATE STREET CORPIncreased5.2MFeb 13, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position4.6MMay 8, 2026
ARCH VENTURE MANAGEMENT, LLCUnchanged4.5MMay 15, 2026
ARCH VENTURE MANAGEMENT, LLCUnchanged4.5MFeb 17, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.